The authors attributed intratumoral delivery with increased antitumor and decreased pro-tumor cytokines/chemokines within the TME which in turn increased the tumor influx of CD8+ T cells, also suggestive of how locally modulating the inflammatory milieu, in this case with tumor lysate-pulsed DCs, can recruit T-cells to the tumor. This evidence concerns the gene CD8A and neoplasm.